Compared side by side

BPC-157 vs VIP: how they differ

Reviewed How we check the libraryPublished by PepVault

The short answer

BPC-157 is a peptide derived from a protective protein in human gastric juice that, in animal studies, speeds the repair of tendons, ligaments, muscle and gut lining. VIP is a neuropeptide the body uses to relax blood vessels and steer immune signaling, used mostly as a nasal spray in protocols for chronic inflammatory response syndrome (CIRS) and mold illness. VIP’s human evidence is small open-label case series, and BPC-157’s is three small uncontrolled pilots.

Side by side

ComparedBPC-157VIP
CategoryHealing & recoveryHealing & recovery
Also known asBody Protection Compound 157, BPC157Vasoactive Intestinal Peptide, VIP neuropeptide
What it isA peptide derived from a protective protein in your stomach.A neuropeptide your body uses to relax blood vessels and steer immune signaling; in animal studies it's a powerful anti-inflammatory.
How it worksSynthetic pentadecapeptide derived from a protein in human gastric juice. In animal studies it promotes angiogenesis, speeds tendon, ligament and muscle healing, modulates dopamine and serotonin systems, and protects the gut lining.Neuropeptide with potent anti-inflammatory effects in animal and cell studies; it also relaxes blood vessels and helps regulate the autonomic nervous system. Its effect on mast cells is mixed: in human mast cells in the lab it can trigger them. Used mainly in CIRS (chronic inflammatory response syndrome) and mold-illness protocols, a use that rests on open-label case series from one clinical group.
Commonly reportedFaster recovery from tendon and ligament injuries, and a calmer gut. It's one of the most widely used peptides in the community; the human studies so far are three small uncontrolled pilots.Flushing or lightheadedness soon after a dose, especially early on, and for people on those protocols a slow lift in brain fog and fatigue over weeks to months. The human evidence is small open-label case series.
Studied rangeResearch range: 200–500 mcg. Studied in research — not a recommendation.Research range: 50 mcg. Studied in research — not a recommendation.
How oftenOnce or twice daily2x daily, intranasal
Half-life~4–6 hours (community estimate for SubQ; not measured in people: in rats and dogs it cleared in under 30 minutes)~2 min IV; intranasal lasts longer locally
RouteSubQ injection, IM injection, Oral (less studied)Intranasal (primary), SubQ injection
Typical runTypically 4–12 weeks. Many run until injury resolves then stop. Some run indefinitely at lower doses. Opinions vary widely.Used in defined cycles in CIRS protocols, often 4+ weeks. Practitioner guidance recommended.
EvidenceEmerging: primarily preclinical / limited human dataModerate: animal studies + some human data
Common side effectsNausea (rare), injection site irritation, vivid dreams, dizzinessFlushing, hypotension at higher doses, headache, lightheadedness

Typical run: Community practice — opinions vary. Not a clinical recommendation.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Taking BPC-157 or VIP? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Week by week

Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.

BPC-157

  • Day 1–7 Week one: early hints, for some
  • Day 7–14 Pain often starts to ease
  • Day 14–21 Pain often eases by week three
  • Day 21–28 Many report a calmer gut
  • Day 28–42 The slower part of repair
  • Day 42–56 Six weeks in: taking stock
  • Day 84+ Past week 12, the data runs thin

Every card for BPC-157, with its sources

VIP

  • Day 1–14 The first two weeks
  • Day 14–60 A slow arc, not a quick change
  • Day 60–120 The long arc

Every card for VIP, with its sources

Together or one or the other

BPC-157 and VIP are a common stack: VIP lists BPC-157 among its common stacks.

Community · VIP

An inflammation-focused trio

Three angles at once: VIP to damp inflammation, LL-37 against microbes, and BPC-157 for gut and tissue repair. Used together in some mold-illness practitioner protocols; no study has tested the combination.

Questions people ask

How long do BPC-157 and VIP last?

The half-life of BPC-157 is ~4–6 hours (community estimate for SubQ; not measured in people: in rats and dogs it cleared in under 30 minutes). The half-life of VIP is ~2 min IV; intranasal lasts longer locally.

How often are BPC-157 and VIP taken?

BPC-157: once or twice daily. Routes: SubQ injection, IM injection, oral (less studied). VIP: 2x daily, intranasal. Routes: Intranasal (primary), subQ injection.

How are BPC-157 and VIP dosed in research?

The research range for BPC-157 is 200–500 mcg. The research range for VIP is 50 mcg. Studied in research — not a recommendation.

What are the common side effects of BPC-157 and VIP?

For BPC-157, the library lists: nausea (rare), injection site irritation, vivid dreams, dizziness. For VIP: flushing, hypotension at higher doses, headache, lightheadedness.

Are BPC-157 and VIP taken together?

BPC-157 and VIP are a common stack: VIP lists BPC-157 among its common stacks. Three angles at once: VIP to damp inflammation, LL-37 against microbes, and BPC-157 for gut and tissue repair. Used together in some mold-illness practitioner protocols; no study has tested the combination.

Each one in full

Track it in the app

PepVault for iPhone

Taking BPC-157 or VIP? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo